How Effective is Atomoxetine in Children and Adolescents?

https://www.thecarlatreport.com/podcast/how-effective-is-atomoxetine-in-children-and-adolescents/

 

Since its FDA approval in 2002, Atomoxetine (brand name Strattera) has become a second or third line option (after stimulants and sometimes after central alpha agonists) for ADHD in both children and adults. With the recent approval of another non-stimulant ADHD medication (viloxazine, brand name Qelbree), this is a good time to revisit atomoxetine. How effective is it? What are some of its pros and cons? This podcast will clarify the position of atomoxetine in our toolbox for treating children and adolescents with ADHD. 

Author
Joshua Feder, M.D. Dr. Feder's Blog

You Might Also Enjoy...

Autism and Medication: Dr Feder's New Algorithm!

This is part 2 because there is a new Child Medication Fact Book for Psychiatric Practice, Second Edition that just came out. Dr. Feder is here to tell us the purpose of the book and to walk us through his new algorithm for supporting autistic kids.

Improving Sleep in Children and Adolescents

We are in the midst of "The Great Sleep Recession." How can we enhance the quality of sleep in children and adolescents? Mara and I dive into sleep on this episode of The Carlat Psychiatry Podcast.